表紙
市場調査レポート

Faron Pharmaceuticals Oy - 製品パイプライン分析

Faron Pharmaceuticals Oy - Product Pipeline Review - 2015

発行 Global Markets Direct 商品コード 251665
出版日 ページ情報 英文 25 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
Faron Pharmaceuticals Oy - 製品パイプライン分析 Faron Pharmaceuticals Oy - Product Pipeline Review - 2015
出版日: 2015年05月27日 ページ情報: 英文 25 Pages
概要

Faron Pharmaceuticals, Ltd. は、血管障害や炎症性疾患、癌の転移と関連した急性外傷、メタボリック・シンドロームの治療薬の発見と開発に取り組んでいる製薬会社です。

当レポートでは、Faron Pharmaceuticals Oyにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Faron Pharmaceuticals Oyの基本情報

Faron Pharmaceuticals Oyの概要

  • 主要情報
  • 企業情報

Faron Pharmaceuticals Oy:R&Dの概要

  • 主な治療範囲

Faron Pharmaceuticals Oy:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Faron Pharmaceuticals Oy:パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 第III相にある製品/併用療法モダリティ

Faron Pharmaceuticals Oy

  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Faron Pharmaceuticals Oy:薬剤プロファイル

  • interferon beta-1a
  • FP-1304
  • FP-1101/1115

Faron Pharmaceuticals Oy:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Faron Pharmaceuticals Oy:最近のパイプライン動向

Faron Pharmaceuticals Oy:休止中のプロジェクト

Faron Pharmaceuticals Oy:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC07146CDB

Summary

Global Markets Direct's, 'Faron Pharmaceuticals Oy - Product Pipeline Review - 2015', provides an overview of the Faron Pharmaceuticals Oy's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Faron Pharmaceuticals Oy's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Faron Pharmaceuticals Oy including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Faron Pharmaceuticals Oy's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Faron Pharmaceuticals Oy's pipeline products

Reasons to buy

  • Evaluate Faron Pharmaceuticals Oy's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Faron Pharmaceuticals Oy in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Faron Pharmaceuticals Oy's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Faron Pharmaceuticals Oy and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Faron Pharmaceuticals Oy
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Faron Pharmaceuticals Oy and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Faron Pharmaceuticals Oy Snapshot
    • Faron Pharmaceuticals Oy Overview
    • Key Information
    • Key Facts
  • Faron Pharmaceuticals Oy - Research and Development Overview
    • Key Therapeutic Areas
  • Faron Pharmaceuticals Oy - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Faron Pharmaceuticals Oy - Pipeline Products Glance
    • Faron Pharmaceuticals Oy - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
    • Faron Pharmaceuticals Oy - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Faron Pharmaceuticals Oy - Drug Profiles
    • interferon beta-1a
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-1304
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • FP-1101/1115
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Faron Pharmaceuticals Oy - Pipeline Analysis
    • Faron Pharmaceuticals Oy - Pipeline Products by Target
    • Faron Pharmaceuticals Oy - Pipeline Products by Route of Administration
    • Faron Pharmaceuticals Oy - Pipeline Products by Molecule Type
    • Faron Pharmaceuticals Oy - Pipeline Products by Mechanism of Action
  • Faron Pharmaceuticals Oy - Recent Pipeline Updates
  • Faron Pharmaceuticals Oy - Dormant Projects
  • Faron Pharmaceuticals Oy - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Faron Pharmaceuticals Oy, Key Information
  • Faron Pharmaceuticals Oy, Key Facts
  • Faron Pharmaceuticals Oy - Pipeline by Indication, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Stage of Development, 2015
  • Faron Pharmaceuticals Oy - Monotherapy Products in Pipeline, 2015
  • Faron Pharmaceuticals Oy - Phase II, 2015
  • Faron Pharmaceuticals Oy - Preclinical, 2015
  • Faron Pharmaceuticals Oy - Discovery, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Target, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Route of Administration, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Molecule Type, 2015
  • Faron Pharmaceuticals Oy - Pipeline Products by Mechanism of Action, 2015
  • Faron Pharmaceuticals Oy - Recent Pipeline Updates, 2015
  • Faron Pharmaceuticals Oy - Dormant Developmental Projects,2015

List of Figures

  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Indication, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Stage of Development, 2015
  • Faron Pharmaceuticals Oy - Monotherapy Products in Pipeline, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Target, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Route of Administration, 2015
  • Faron Pharmaceuticals Oy - Pipeline by Top 10 Molecule Type, 2015
  • Faron Pharmaceuticals Oy - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top